Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 33, 2022 - Issue 3
Submit an article Journal homepage
328
Views
7
CrossRef citations to date
0
Altmetric
Articles

Dermoscopic evaluation of tranexamic acid versus Vitamin C, with microneedling in the treatment of melasma: a comparative, split-face, single-blinded study

Asmaa Ibrahim TahounDepartment of Dermatology, Cairo University, Cairo, Egypt
,
Wedad Zoheir MostafaDepartment of Dermatology, Cairo University, Cairo, EgyptORCID Iconhttps://orcid.org/0000-0001-8464-8549
ORCID Icon &
Marwa Ahmed AmerDepartment of Dermatology, Cairo University, Cairo, EgyptCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6560-5460
ORCID Icon
Pages 1623-1629 | Received 11 Nov 2020, Accepted 25 Dec 2020, Published online: 12 Jan 2021

References

  • Aboobacker S, Karthikeyan K. Melasma and hypothyroidism: conflicting coexistence. J Clin Exp Dermatol Res. 2017;08(06):429–431.
  • Tamega AA, Miot LD, Bonfietti C, et al. Clinical patterns and epidemiological characteristics of facial melasma in Brazilian women. J Eur Acad Dermatol Venereol. 2013;27(2):151–156.
  • Sonthalia S, Sarkar R. Etiopathogenesis of melasma. Pigment Int. 2015;2(1):21–27.
  • Geddes ER, Li JY, Robinson DM, et al. A review of melasma treatment focusing on laser and light devices. Semin Cutan Med Surg. 2016;35(4):223–232.
  • Kim EH, Kim YC, Lee ES, et al. The vascular characteristics of melasma. J Dermatol Sci. 2007;46(2):111–116.
  • Kwon SH, Hwang YJ, Lee SK, et al. Heterogeneous pathology of melasma and its clinical implications. Int J Mol Sci. 2016;17(6):824.
  • Ogbechie-Godec OA, Elbuluk N. Melasma: an up-to-date comprehensive review. Dermatol Ther. 2017;7(3):305–318.
  • McCormack PL. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs. 2012;72(5):585–617.
  • George A. Tranexamic acid: an emerging depigmenting agent. Pigment Int. 2016;3(2):66–71.
  • Pullar JM, Carr AC, Vissers MCM. The roles of vitamin C in skin health. Nutrients. 2017;8:866–893.
  • Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–216.
  • Lee A. Recent progress in melasma pathogenesis. Pigment Cell Melanoma Res. 2015;28(6):648–660.
  • Chan YH. Biostatistics102: quantitative data – parametric & non-parametric tests. Singapore Med J. 2003;44(8):391–396.
  • Chan YH. Biostatistics qualitative data –tests of independence. Singapore Med J. 2003;103(10):498–503.
  • Chan YH. Biostatistics 104: correlational analysis. Singapore Med J. 2003;44(12):614–619.
  • Rodrigues M, Pandya AG. Melasma: clinical diagnosis and management options. Australas J Dermatol. 2015;56(3):151.
  • Sarkar R, Arora P, Garg KV. Cosmeceuticals for hyperpigmentation: what is available? J Cutan Aesthet Surg. 2013;6(1):4–11.
  • Achar A, Rathi SK. Melasma: a clinico-epidemiological study of 312 cases. Indian J Dermatol. 2011;56(4):380–382.
  • Chatterjee M, Vasudevan B. Recent advances in melasma. Pigment Int. 2014;1(2):70–80.
  • Handel AC, Lima PB, Tonolli VM, et al. Risk factors for facial melasma in women: a case-control study. Br J Dermatol. 2014b;171(3):588–594.
  • Alves GF, Nogueira LSC, Varella TCN. Dermatologia e gestacao. An Bras Dermatol. 2005;80(2):179–186.
  • Ortonne JP, Arellano I, Berneburg M, et al. A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma. J Eur Acad Dermatol Venereol. 2009;23(11):1254–1262.
  • Guinot C, Cheffai S, Latreille J, et al. Aggravating factors for melasma: a prospective study in 197 Tunisian patients. J Eur Acad Dermatol Venerol. 2010;24(9):1060–1069.
  • Hughes BR. Melasma occurring in twin sisters. J Am Acad Dermatol. 1987;17(5):841.
  • Regazzetti C, Sormani L, Debayle D, et al. Melanocytes sense blue light and regulate pigmentation through Opsin-3. J Invest Dermatol. 2018;138(1):171–178.
  • Sarkar R, Ailawadi P, Sh G. Melasma in men: a review of clinical, etiological, and management issues. J Clin Aesthet Dermatol. 2018;11(2):53–59.
  • Kanechorn Na Ayuthaya P, Niumphradit N, Manosroi A, et al. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double blind randomized controlled clinical trial. J Cosmet Laser Ther. 2012;14(3):150–154.
  • Taraz M, Niknam S, Ehsani AH. Tranexamic acid in treatment of melasma: a comprehensive review of clinical studies. Dermatol Ther. 2017;30(3):1–8.
  • Ebrahimi B, Naeini FF. Topical tranexamic acid as a promising treatment for melasma. J Res Med Sci. 2014;19(8):753–757.
  • Banihashemi M, Zabolinejad N, Jaafari MR, et al. Comparison of therapeutic effects of liposomal tranexamic acid and conventional hydroquinone on melasma. J Cosmet Dermatol. 2015;14(3):174–177.
  • Telang PS. Vitamin C in dermatology. Indian Dermatol Online J. 2013;4(2):143–146.
  • Morgaonkar M, Gupta S, Vijay A, et al. Melasma: its impact on quality of life. Pigment Int. 2017;4(1):39–44.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.